APO Research
Talk to an analyst

APO RESEARCH · REPORT

Encephalitis Vaccination

Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito’s classes. People and many animals may be infection source after infection Encephalitis virus.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito’s classes. People and many animals may be infection source after infection Encephalitis virus.

Selected research

Industry Growth & Trends

Global Encephalitis Vaccination Industry Growth and Trends Forecast to 2032

2 January 202692 pages

Choose your research edition.

Industry ResearchEncephalitis Vaccination Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Encephalitis Vaccination Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Encephalitis Vaccination Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Encephalitis Vaccination Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Encephalitis Vaccination Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito’s classes. People and many animals may be infection source after infection Encephalitis virus.

The world's leading manufacturers of JE vaccines are Novartis, Sanofi, Chengdu Institute of Biological Products, Wuhan Institute of Biological Products, Lanzhou Institute of Biological Products, Beijing Taitan, Valneva, Bharat Biotech and Liaoning Chengda, etc.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Encephalitis Vaccination market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Encephalitis Vaccination market size, estimates, and forecasts are presented in terms of sales volume (10K Person-time) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Encephalitis Vaccination market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Encephalitis Vaccination.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Encephalitis Vaccination market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Encephalitis Vaccination Market by Company

Novartis

Sanofi

Chengdu Institute of Biological Products

Wuhan Institute of Biological Products

Lanzhou Institute of Biological Products

Beijing Taitan

Valneva

Bharat Biotech

Liaoning Chengda

Encephalitis Vaccination Segment by Type

Encephalitis B Vaccine

Encephalitis Attenuated Live Vaccine

Encephalitis Vaccination Segment by Application

Public Hospital

Private Hospital

Clinic

Other

Encephalitis Vaccination Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Encephalitis Vaccination market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Encephalitis Vaccination and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Encephalitis Vaccination.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Encephalitis Vaccination manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Encephalitis Vaccination in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Encephalitis B Vaccine Table 2. Major Company of Encephalitis Attenuated Live Vaccine Table 3. Global Encephalitis Vaccination Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Encephalitis Vaccination Sales by Type (2021-2026) & (10K Person-time) Table 5. Global Encephalitis Vaccination Sales Market Share in Volume by Type (2021-2026) Table 6. Global Encephalitis Vaccination Sales by Type (2021-2026) & (US$ Million) Table 7. Global Encephalitis Vaccination Sales Market Share in Value by Type (2021-2026) Table 8. Global Encephalitis Vaccination Price by Type (2021-2026) & (USD/Person-time) Table 9. Global Encephalitis Vaccination Sales by Type (2027-2032) & (10K Person-time) Table 10. Global Encephalitis Vaccination Sales Market Share in Volume by Type (2027-2032) Table 11. Global Encephalitis Vaccination Sales by Type (2027-2032) & (US$ Million) Table 12. Global Encephalitis Vaccination Sales Market Share in Value by Type (2027-2032) Table 13. Global Encephalitis Vaccination Price by Type (2027-2032) & (USD/Person-time) Table 14. North America Encephalitis Vaccination Sales by Type (2021-2026) & (10K Person-time) Table 15. North America Encephalitis Vaccination Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Encephalitis Vaccination Sales by Type (2021-2026) & (10K Person-time) Table 17. Europe Encephalitis Vaccination Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Encephalitis Vaccination Sales by Type (2021-2026) & (10K Person-time) Table 19. Asia-Pacific Encephalitis Vaccination Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Encephalitis Vaccination Sales by Type (2021-2026) & (10K Person-time) Table 21. Latin America Encephalitis Vaccination Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Encephalitis Vaccination Sales by Type (2021-2026) & (10K Person-time) Table 23. Middle East and Africa Encephalitis Vaccination Sales by Type (2021-2026) & (US$ Million) Table 24. Encephalitis Vaccination Industry Trends Table 25. Encephalitis Vaccination Industry Drivers Table 26. Encephalitis Vaccination Industry Opportunities and Challenges Table 27. Encephalitis Vaccination Industry Restraints Table 28. Global Encephalitis Vaccination Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Encephalitis Vaccination Revenue Market Share by Company (2021-2026) Table 30. Global Encephalitis Vaccination Sales by Company (2021-2026) & (10K Person-time) Table 31. Global Encephalitis Vaccination Sales Share by Company (2021-2026) Table 32. Global Encephalitis Vaccination Market Price by Company (2021-2026) & (USD/Person-time) Table 33. Global Encephalitis Vaccination Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Encephalitis Vaccination Major Company Production Sites and Headquarters Table 35. Global Encephalitis Vaccination Company, Product Type & Application Table 36. Global Encephalitis Vaccination Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Encephalitis Vaccination by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Encephalitis Vaccination Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Encephalitis Vaccination Sales by Region (2021-2026) & (10K Person-time) Table 41. Global Encephalitis Vaccination Sales Market Share in Volume by Region (2021-2026) Table 42. Global Encephalitis Vaccination Sales by Region (2021-2026) & (US$ Million) Table 43. Global Encephalitis Vaccination Sales Market Share in Value by Region (2021-2026) Table 44. Global Encephalitis Vaccination Sales (10K Person-time), Value (US$ Million), Price (USD/Person-time) and Gross Margin (2021-2026) Table 45. Global Encephalitis Vaccination Sales by Region (2027-2032) & (10K Person-time) Table 46. Global Encephalitis Vaccination Sales Market Share in Volume by Region (2027-2032) Table 47. Global Encephalitis Vaccination Sales by Region (2027-2032) & (US$ Million) Table 48. Global Encephalitis Vaccination Sales Market Share in Value by Region (2027-2032) Table 49. Global Encephalitis Vaccination Sales (10K Person-time), Value (US$ Million), Price (USD/Person-time) and Gross Margin (2027-2032) Table 50. Global Encephalitis Vaccination Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Encephalitis Vaccination Sales by Application (2021-2026) & (10K Person-time) Table 52. Global Encephalitis Vaccination Sales Market Share in Volume by Application (2021-2026) Table 53. Global Encephalitis Vaccination Sales by Application (2021-2026) & (US$ Million) Table 54. Global Encephalitis Vaccination Sales Market Share in Value by Application (2021-2026) Table 55. Global Encephalitis Vaccination Price by Application (2021-2026) & (USD/Person-time) Table 56. Global Encephalitis Vaccination Sales by Application (2027-2032) & (10K Person-time) Table 57. Global Encephalitis Vaccination Sales Market Share in Volume by Application (2027-2032) Table 58. Global Encephalitis Vaccination Sales by Application (2027-2032) & (US$ Million) Table 59. Global Encephalitis Vaccination Sales Market Share in Value by Application (2027-2032) Table 60. Global Encephalitis Vaccination Price by Application (2027-2032) & (USD/Person-time) Table 61. North America Encephalitis Vaccination Sales by Application (2021-2026) & (10K Person-time) Table 62. North America Encephalitis Vaccination Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Encephalitis Vaccination Sales by Application (2021-2026) & (10K Person-time) Table 64. Europe Encephalitis Vaccination Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Encephalitis Vaccination Sales by Application (2021-2026) & (10K Person-time) Table 66. Asia-Pacific Encephalitis Vaccination Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Encephalitis Vaccination Sales by Application (2021-2026) & (10K Person-time) Table 68. Latin America Encephalitis Vaccination Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Encephalitis Vaccination Sales by Application (2021-2026) & (10K Person-time) Table 70. Middle East and Africa Encephalitis Vaccination Sales by Application (2021-2026) & (US$ Million) Table 71. Novartis Company Information Table 72. Novartis Business Overview Table 73. Novartis Encephalitis Vaccination Sales (10K Person-time), Revenue (US$ Million), Price (USD/Person-time) and Gross Margin (2021-2026) Table 74. Novartis Encephalitis Vaccination Product Portfolio Table 75. Novartis Recent Development Table 76. Sanofi Company Information Table 77. Sanofi Business Overview Table 78. Sanofi Encephalitis Vaccination Sales (10K Person-time), Revenue (US$ Million), Price (USD/Person-time) and Gross Margin (2021-2026) Table 79. Sanofi Encephalitis Vaccination Product Portfolio Table 80. Sanofi Recent Development Table 81. Chengdu Institute of Biological Products Company Information Table 82. Chengdu Institute of Biological Products Business Overview Table 83. Chengdu Institute of Biological Products Encephalitis Vaccination Sales (10K Person-time), Revenue (US$ Million), Price (USD/Person-time) and Gross Margin (2021-2026) Table 84. Chengdu Institute of Biological Products Encephalitis Vaccination Product Portfolio Table 85. Chengdu Institute of Biological Products Recent Development Table 86. Wuhan Institute of Biological Products Company Information Table 87. Wuhan Institute of Biological Products Business Overview Table 88. Wuhan Institute of Biological Products Encephalitis Vaccination Sales (10K Person-time), Revenue (US$ Million), Price (USD/Person-time) and Gross Margin (2021-2026) Table 89. Wuhan Institute of Biological Products Encephalitis Vaccination Product Portfolio Table 90. Wuhan Institute of Biological Products Recent Development Table 91. Lanzhou Institute of Biological Products Company Information Table 92. Lanzhou Institute of Biological Products Business Overview Table 93. Lanzhou Institute of Biological Products Encephalitis Vaccination Sales (10K Person-time), Revenue (US$ Million), Price (USD/Person-time) and Gross Margin (2021-2026) Table 94. Lanzhou Institute of Biological Products Encephalitis Vaccination Product Portfolio Table 95. Lanzhou Institute of Biological Products Recent Development Table 96. Beijing Taitan Company Information Table 97. Beijing Taitan Business Overview Table 98. Beijing Taitan Encephalitis Vaccination Sales (10K Person-time), Revenue (US$ Million), Price (USD/Person-time) and Gross Margin (2021-2026) Table 99. Beijing Taitan Encephalitis Vaccination Product Portfolio Table 100. Beijing Taitan Recent Development Table 101. Valneva Company Information Table 102. Valneva Business Overview Table 103. Valneva Encephalitis Vaccination Sales (10K Person-time), Revenue (US$ Million), Price (USD/Person-time) and Gross Margin (2021-2026) Table 104. Valneva Encephalitis Vaccination Product Portfolio Table 105. Valneva Recent Development Table 106. Bharat Biotech Company Information Table 107. Bharat Biotech Business Overview Table 108. Bharat Biotech Encephalitis Vaccination Sales (10K Person-time), Revenue (US$ Million), Price (USD/Person-time) and Gross Margin (2021-2026) Table 109. Bharat Biotech Encephalitis Vaccination Product Portfolio Table 110. Bharat Biotech Recent Development Table 111. Liaoning Chengda Company Information Table 112. Liaoning Chengda Business Overview Table 113. Liaoning Chengda Encephalitis Vaccination Sales (10K Person-time), Revenue (US$ Million), Price (USD/Person-time) and Gross Margin (2021-2026) Table 114. Liaoning Chengda Encephalitis Vaccination Product Portfolio Table 115. Liaoning Chengda Recent Development Table 116. North America Encephalitis Vaccination Market Size Growth Rate (CAGR) by Country (10K Person-time): 2021 VS 2025 VS 2032 Table 117. North America Encephalitis Vaccination Sales by Country (2021-2026) & (10K Person-time) Table 118. North America Encephalitis Vaccination Sales Market Share by Country (2021-2026) Table 119. North America Encephalitis Vaccination Sales Forecast by Country (2027-2032) & (10K Person-time) Table 120. North America Encephalitis Vaccination Sales Market Share Forecast by Country (2027-2032) Table 121. North America Encephalitis Vaccination Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Encephalitis Vaccination Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Encephalitis Vaccination Market Share by Country (2021-2026) Table 124. North America Encephalitis Vaccination Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Encephalitis Vaccination Market Share Forecast by Country (2027-2032) Table 126. Europe Encephalitis Vaccination Market Size Growth Rate (CAGR) by Country (10K Person-time): 2021 VS 2025 VS 2032 Table 127. Europe Encephalitis Vaccination Sales by Country (2021-2026) & (10K Person-time) Table 128. Europe Encephalitis Vaccination Sales Market Share by Country (2021-2026) Table 129. Europe Encephalitis Vaccination Sales Forecast by Country (2027-2032) & (10K Person-time) Table 130. Europe Encephalitis Vaccination Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Encephalitis Vaccination Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Encephalitis Vaccination Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Encephalitis Vaccination Market Share by Country (2021-2026) Table 134. Europe Encephalitis Vaccination Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Encephalitis Vaccination Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Encephalitis Vaccination Market Size Growth Rate (CAGR) by Country (10K Person-time): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Encephalitis Vaccination Sales by Country (2021-2026) & (10K Person-time) Table 138. Asia-Pacific Encephalitis Vaccination Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Encephalitis Vaccination Sales Forecast by Country (2027-2032) & (10K Person-time) Table 140. Asia-Pacific Encephalitis Vaccination Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Encephalitis Vaccination Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Encephalitis Vaccination Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Encephalitis Vaccination Market Share by Country (2021-2026) Table 144. Asia-Pacific Encephalitis Vaccination Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Encephalitis Vaccination Market Share Forecast by Country (2027-2032) Table 146. Latin America Encephalitis Vaccination Market Size Growth Rate (CAGR) by Country (10K Person-time): 2021 VS 2025 VS 2032 Table 147. Latin America Encephalitis Vaccination Sales by Country (2021-2026) & (10K Person-time) Table 148. Latin America Encephalitis Vaccination Sales Market Share by Country (2021-2026) Table 149. Latin America Encephalitis Vaccination Sales Forecast by Country (2027-2032) & (10K Person-time) Table 150. Latin America Encephalitis Vaccination Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Encephalitis Vaccination Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Encephalitis Vaccination Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Encephalitis Vaccination Market Share by Country (2021-2026) Table 154. Latin America Encephalitis Vaccination Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Encephalitis Vaccination Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Encephalitis Vaccination Market Size Growth Rate (CAGR) by Country (10K Person-time): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Encephalitis Vaccination Sales by Country (2021-2026) & (10K Person-time) Table 158. Middle East and Africa Encephalitis Vaccination Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Encephalitis Vaccination Sales Forecast by Country (2027-2032) & (10K Person-time) Table 160. Middle East and Africa Encephalitis Vaccination Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Encephalitis Vaccination Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Encephalitis Vaccination Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Encephalitis Vaccination Market Share by Country (2021-2026) Table 164. Middle East and Africa Encephalitis Vaccination Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Encephalitis Vaccination Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Encephalitis Vaccination Distributors List Table 169. Encephalitis Vaccination Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Encephalitis Vaccination Image Figure 2. Global Encephalitis Vaccination Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Encephalitis Vaccination Market Size (2021-2032) & (US$ Million) Figure 4. Global Encephalitis Vaccination Sales (2021-2032) & (10K Person-time) Figure 5. Encephalitis B Vaccine Image Figure 6. Global Encephalitis B Vaccine Sales YoY Growth (2021-2032) & (10K Person-time) Figure 7. Encephalitis Attenuated Live Vaccine Image Figure 8. Global Encephalitis Attenuated Live Vaccine Sales YoY Growth (2021-2032) & (10K Person-time) Figure 9. Global Encephalitis Vaccination Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Encephalitis Vaccination Market Share by Type 2025 VS 2032 Figure 11. North America Encephalitis Vaccination Sales Market Share in Volume by Type in 2025 Figure 12. North America Encephalitis Vaccination Sales Market Share in Value by Type in 2025 Figure 13. Europe Encephalitis Vaccination Sales Market Share in Volume by Type in 2025 Figure 14. Europe Encephalitis Vaccination Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Encephalitis Vaccination Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Encephalitis Vaccination Sales Market Share in Value by Type in 2025 Figure 17. Latin America Encephalitis Vaccination Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Encephalitis Vaccination Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Encephalitis Vaccination Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Encephalitis Vaccination Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Encephalitis Vaccination Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Public Hospital Image Figure 24. Global Public Hospital Sales YoY Growth (2021-2032) & (10K Person-time) Figure 25. Private Hospital Image Figure 26. Global Private Hospital Sales YoY Growth (2021-2032) & (10K Person-time) Figure 27. Clinic Image Figure 28. Global Clinic Sales YoY Growth (2021-2032) & (10K Person-time) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (10K Person-time) Figure 31. Global Encephalitis Vaccination Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Encephalitis Vaccination Market Share by Application 2025 VS 2032 Figure 33. North America Encephalitis Vaccination Sales Market Share in Volume by Application in 2025 Figure 34. North America Encephalitis Vaccination Sales Market Share in Value by Application in 2025 Figure 35. Europe Encephalitis Vaccination Sales Market Share in Volume by Application in 2025 Figure 36. Europe Encephalitis Vaccination Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Encephalitis Vaccination Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Encephalitis Vaccination Sales Market Share in Value by Application in 2025 Figure 39. Latin America Encephalitis Vaccination Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Encephalitis Vaccination Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Encephalitis Vaccination Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Encephalitis Vaccination Sales Market Share in Value by Application in 2025 Figure 43. North America Encephalitis Vaccination Sales by Country: 2021 VS 2025 VS 2032 (10K Person-time) Figure 44. North America Encephalitis Vaccination Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Encephalitis Vaccination Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Encephalitis Vaccination Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Encephalitis Vaccination Sales by Country: 2021 VS 2025 VS 2032 (10K Person-time) Figure 48. Europe Encephalitis Vaccination Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Encephalitis Vaccination Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Encephalitis Vaccination Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Encephalitis Vaccination Sales by Country: 2021 VS 2025 VS 2032 (10K Person-time) Figure 52. Asia-Pacific Encephalitis Vaccination Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Encephalitis Vaccination Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Encephalitis Vaccination Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Encephalitis Vaccination Sales by Country: 2021 VS 2025 VS 2032 (10K Person-time) Figure 56. Latin America Encephalitis Vaccination Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Encephalitis Vaccination Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Encephalitis Vaccination Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Encephalitis Vaccination Sales by Country: 2021 VS 2025 VS 2032 (10K Person-time) Figure 60. Middle East and Africa Encephalitis Vaccination Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Encephalitis Vaccination Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Encephalitis Vaccination Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Encephalitis Vaccination Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Encephalitis Vaccination Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Encephalitis B Vaccine
  • Encephalitis Attenuated Live Vaccine
Applications
  • Public Hospital
  • Private Hospital
  • Clinic
  • Other
Companies covered
  • Novartis
  • Sanofi
  • Chengdu Institute of Biological Products
  • Wuhan Institute of Biological Products
  • Lanzhou Institute of Biological Products
  • Beijing Taitan
  • Valneva
  • Bharat Biotech
  • Liaoning Chengda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Encephalitis Vaccination Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Encephalitis Vaccination Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Encephalitis Vaccination Market by Type
  6. 1.3.1 Encephalitis B Vaccine
  7. 1.3.2 Encephalitis Attenuated Live Vaccine
  8. 1.4 Global Encephalitis Vaccination Market Size by Type
  9. 1.4.1 Global Encephalitis Vaccination Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Encephalitis Vaccination Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Encephalitis Vaccination Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Encephalitis Vaccination Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Encephalitis Vaccination Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Encephalitis Vaccination Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Encephalitis Vaccination Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Encephalitis Vaccination Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Encephalitis Vaccination Industry Trends
  2. 2.2 Encephalitis Vaccination Industry Drivers
  3. 2.3 Encephalitis Vaccination Industry Opportunities and Challenges
  4. 2.4 Encephalitis Vaccination Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Encephalitis Vaccination Revenue (2021-2026)
  2. 3.2 Global Top Players by Encephalitis Vaccination Sales (2021-2026)
  3. 3.3 Global Top Players by Encephalitis Vaccination Price (2021-2026)
  4. 3.4 Global Encephalitis Vaccination Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Encephalitis Vaccination Major Company Production Sites & Headquarters
  6. 3.6 Global Encephalitis Vaccination Company, Product Type & Application
  7. 3.7 Global Encephalitis Vaccination Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Encephalitis Vaccination Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Encephalitis Vaccination Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Encephalitis Vaccination Tier 1, Tier 2, and Tier 3
4 Encephalitis Vaccination Regional Status and Outlook
  1. 4.1 Global Encephalitis Vaccination Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Encephalitis Vaccination Historic Market Size by Region
  3. 4.2.1 Global Encephalitis Vaccination Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Encephalitis Vaccination Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Encephalitis Vaccination Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Encephalitis Vaccination Forecasted Market Size by Region
  7. 4.3.1 Global Encephalitis Vaccination Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Encephalitis Vaccination Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Encephalitis Vaccination Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Encephalitis Vaccination by Application
  1. 5.1 Encephalitis Vaccination Market by Application
  2. 5.1.1 Public Hospital
  3. 5.1.2 Private Hospital
  4. 5.1.3 Clinic
  5. 5.1.4 Other
  6. 5.2 Global Encephalitis Vaccination Market Size by Application
  7. 5.2.1 Global Encephalitis Vaccination Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Encephalitis Vaccination Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Encephalitis Vaccination Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Encephalitis Vaccination Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Encephalitis Vaccination Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Encephalitis Vaccination Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Encephalitis Vaccination Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Encephalitis Vaccination Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Encephalitis Vaccination Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Encephalitis Vaccination Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Encephalitis Vaccination Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Encephalitis Vaccination Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Chengdu Institute of Biological Products
  14. 6.3.1 Chengdu Institute of Biological Products Company Information
  15. 6.3.2 Chengdu Institute of Biological Products Business Overview
  16. 6.3.3 Chengdu Institute of Biological Products Encephalitis Vaccination Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Chengdu Institute of Biological Products Encephalitis Vaccination Product Portfolio
  18. 6.3.5 Chengdu Institute of Biological Products Recent Developments
  19. 6.4 Wuhan Institute of Biological Products
  20. 6.4.1 Wuhan Institute of Biological Products Company Information
  21. 6.4.2 Wuhan Institute of Biological Products Business Overview
  22. 6.4.3 Wuhan Institute of Biological Products Encephalitis Vaccination Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Wuhan Institute of Biological Products Encephalitis Vaccination Product Portfolio
  24. 6.4.5 Wuhan Institute of Biological Products Recent Developments
  25. 6.5 Lanzhou Institute of Biological Products
  26. 6.5.1 Lanzhou Institute of Biological Products Company Information
  27. 6.5.2 Lanzhou Institute of Biological Products Business Overview
  28. 6.5.3 Lanzhou Institute of Biological Products Encephalitis Vaccination Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Lanzhou Institute of Biological Products Encephalitis Vaccination Product Portfolio
  30. 6.5.5 Lanzhou Institute of Biological Products Recent Developments
  31. 6.6 Beijing Taitan
  32. 6.6.1 Beijing Taitan Company Information
  33. 6.6.2 Beijing Taitan Business Overview
  34. 6.6.3 Beijing Taitan Encephalitis Vaccination Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Beijing Taitan Encephalitis Vaccination Product Portfolio
  36. 6.6.5 Beijing Taitan Recent Developments
  37. 6.7 Valneva
  38. 6.7.1 Valneva Company Information
  39. 6.7.2 Valneva Business Overview
  40. 6.7.3 Valneva Encephalitis Vaccination Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Valneva Encephalitis Vaccination Product Portfolio
  42. 6.7.5 Valneva Recent Developments
  43. 6.8 Bharat Biotech
  44. 6.8.1 Bharat Biotech Company Information
  45. 6.8.2 Bharat Biotech Business Overview
  46. 6.8.3 Bharat Biotech Encephalitis Vaccination Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bharat Biotech Encephalitis Vaccination Product Portfolio
  48. 6.8.5 Bharat Biotech Recent Developments
  49. 6.9 Liaoning Chengda
  50. 6.9.1 Liaoning Chengda Company Information
  51. 6.9.2 Liaoning Chengda Business Overview
  52. 6.9.3 Liaoning Chengda Encephalitis Vaccination Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Liaoning Chengda Encephalitis Vaccination Product Portfolio
  54. 6.9.5 Liaoning Chengda Recent Developments
7 North America by Country
  1. 7.1 North America Encephalitis Vaccination Sales by Country
  2. 7.1.1 North America Encephalitis Vaccination Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Encephalitis Vaccination Sales by Country (2021-2026)
  4. 7.1.3 North America Encephalitis Vaccination Sales Forecast by Country (2027-2032)
  5. 7.2 North America Encephalitis Vaccination Market Size by Country
  6. 7.2.1 North America Encephalitis Vaccination Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Encephalitis Vaccination Market Size by Country (2021-2026)
  8. 7.2.3 North America Encephalitis Vaccination Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Encephalitis Vaccination Sales by Country
  2. 8.1.1 Europe Encephalitis Vaccination Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Encephalitis Vaccination Sales by Country (2021-2026)
  4. 8.1.3 Europe Encephalitis Vaccination Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Encephalitis Vaccination Market Size by Country
  6. 8.2.1 Europe Encephalitis Vaccination Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Encephalitis Vaccination Market Size by Country (2021-2026)
  8. 8.2.3 Europe Encephalitis Vaccination Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Encephalitis Vaccination Sales by Country
  2. 9.1.1 Asia-Pacific Encephalitis Vaccination Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Encephalitis Vaccination Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Encephalitis Vaccination Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Encephalitis Vaccination Market Size by Country
  6. 9.2.1 Asia-Pacific Encephalitis Vaccination Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Encephalitis Vaccination Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Encephalitis Vaccination Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Encephalitis Vaccination Sales by Country
  2. 10.1.1 South America Encephalitis Vaccination Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Encephalitis Vaccination Sales by Country (2021-2026)
  4. 10.1.3 South America Encephalitis Vaccination Sales Forecast by Country (2027-2032)
  5. 10.2 South America Encephalitis Vaccination Market Size by Country
  6. 10.2.1 South America Encephalitis Vaccination Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Encephalitis Vaccination Market Size by Country (2021-2026)
  8. 10.2.3 South America Encephalitis Vaccination Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Encephalitis Vaccination Sales by Country
  2. 11.1.1 Middle East and Africa Encephalitis Vaccination Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Encephalitis Vaccination Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Encephalitis Vaccination Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Encephalitis Vaccination Market Size by Country
  6. 11.2.1 Middle East and Africa Encephalitis Vaccination Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Encephalitis Vaccination Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Encephalitis Vaccination Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Encephalitis Vaccination Value Chain Analysis
  2. 12.1.1 Encephalitis Vaccination Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Encephalitis Vaccination Production Mode & Process
  7. 12.2 Encephalitis Vaccination Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Encephalitis Vaccination Distributors
  10. 12.2.3 Encephalitis Vaccination Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst